Samira Fafi-Kremer

University of Strasbourg

France

Research Interests

Explore related searches

Professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (7)

Firouzé Bani-Sadr

FRANCE

View details

Sabrina Bibi-Triki

Inserm u1183

FRANCE

View details

Clíona Ní Cheallaigh

Associate Professor

Trinity College Dublin

IRELAND

View details

Maxime HENTZIEN

Full Professor in Infectious Diseases

Université de Reims Champagne-Ardenne

FRANCE

View details

Sarah Merkling

Institut Pasteur

FRANCE

View details

Mirjana Radosavljevic

Head of department/MD,PhD

Hôpitaux universitaires de Strasbourg

FRANCE

View details

Seiamak Bahram

Professor of Immunology

University of Strasbourg

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Samira Fafi-Kremer

Research Interests

Explore related searches

Contact this professor

Articles (10)

Direct Zeptomole Detection of RNA Biomarkers by Ultrabright Fluorescent Nanoparticles on Magnetic Beads

Neutralizing antibodies as key players in preventing BK polyomavirus replication: Insights from bench to bedside

Torque teno virus viral load predicts SARS‐CoV‐2 vaccine response in kidney transplant recipients

Tick-borne encephalitis in pediatrics: An often overlooked diagnosis

Dolutegravir-based dual maintenance regimens combined with lamivudine/emtricitabine or rilpivirine: risk of virological failure in a real-life setting

Torque teno virus DNA load as a predictive marker of antibody response to a three-dose regimen of COVID-19 mRNA-based vaccine in lung transplant recipients

Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort.

Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection.

COVID-19 exposure in SARS-CoV-2-seropositive hospital staff members during the first pandemic wave at Strasbourg University Hospital, France.

Cellular and humoral immunity after the third dose of SARS-CoV-2 vaccine in patients treated with rituximab.

Collaborators (7)

Firouzé Bani-Sadr

Sabrina Bibi-Triki

Clíona Ní Cheallaigh

Maxime HENTZIEN

Sarah Merkling

Mirjana Radosavljevic

Seiamak Bahram

Make your next move.